Literature DB >> 21147279

Care for patients with ultra-rare disorders.

Raoul C M Hennekam1.   

Abstract

There is increasing attention by policy makers and health authorities for rare disorders (by definition prevalence <1:2000). The attention for ultra-rare disorders (suggested prevalence one-thousandth of rare disorders, so <1:2,000,000) is very limited however. Here some aspects of organizing adequate care for individuals with ultra-rare disorders in a European setting are discussed. Individual ultra-rare disorders are by definition very uncommon but it can be calculated that as a group they form a considerable part of the total group of persons with rare disorders in the European Community (EC). Diagnostics and regular care for individuals with rare disorders is being arranged in national centres of expertise, but due to small individual numbers this is not possible for ultra-rare disorders. A secure database on the internet to which patients with unknown diagnoses from all countries within the EC can be uploaded using standardized terminology and including clinical pictures will be needed to allow for recognition of comparable phenotypes in patients and, thus, establishing rare diagnoses. Due to the large distances between the places where patients live and their large numbers regular care has to be provided locally and centres of excellence will have to function virtually through e-mail consulting. The use of wiki's that are accessible to patients and families to upload data will help to disseminate knowledge and experience. It will be extremely difficult to obtain sufficient funds for research in ultra-rare disorders. It is suggested that the many very small support groups for ultra-rare disorders organize themselves in umbrella organisations of such size that policy makers and grant providing bodies will consult them for their strategies. The role of individuals with ultra-rare disorders themselves, or their families, in obtaining access to all advantages modern medicine can provide will therefore be large.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21147279     DOI: 10.1016/j.ejmg.2010.12.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  27 in total

1.  Neuromuscular disease: Muscular dystrophy--something new on God's green earth?

Authors:  Alessandra Ferlini
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

Review 2.  Infantile hypertrophic pyloric stenosis--genetics and syndromes.

Authors:  Babette Peeters; Marc A Benninga; Raoul C M Hennekam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-10       Impact factor: 46.802

3.  A comparative study of patients' perceptions of genetic and genomic medicine services in California and Malaysia.

Authors:  Emily Qian; Meow-Keong Thong; Pamela Flodman; Jay Gargus
Journal:  J Community Genet       Date:  2018-12-03

4.  Chapter 3 - Restoring Vision to the Blind: Gene Therapy for Vision Loss.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

5.  Biallelic loss of EEF1D function links heat shock response pathway to autosomal recessive intellectual disability.

Authors:  Sibel Aylin Ugur Iseri; Emrah Yucesan; Feyza Nur Tuncer; Mustafa Calik; Yesim Kesim; Gunes Altiokka Uzun; Ugur Ozbek
Journal:  J Hum Genet       Date:  2019-02-21       Impact factor: 3.172

Review 6.  Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges.

Authors:  Antonello Di Paolo; Elena Arrigoni
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

7.  Barber-Say Syndrome and Ablepharon-Macrostomia Syndrome: A Patient's View.

Authors:  Beatrice De Maria; Tresia de Jager; Caitlin Sarubbi; Oliver Bartsch; Alberto Bianchi; Francesco Brancati; Hon-Yin B Chung; Albert David; Ariana Kariminejad; Maura Foresti; Marina Gallottini; Bertrand Isidor; Shannon Marchegiani; Fabiana Martins; Laura Mazzanti; Nathalie Roche; Ankur Singh; Cathy Stevens; Kenichi Suga; Martin Zenker; Raoul C Hennekam
Journal:  Mol Syndromol       Date:  2017-04-27

8.  Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.

Authors:  Maryam Khan; Raheel Iftikhar; Tariq Ghafoor; Fayyaz Hussain; Qamar Un Nisa Chaudhry; Syed Kamran Mahmood; Nighat Shahbaz; Mehreen Ali Khan; Tariq Azam Khattak; Ghassan Umair Shamshad; Jahanzeb Rehman; Sundas Ali; Zunaira Shah; Abdul Rafae; Muhammad Farhan; Faiz Anwer; Parvez Ahmed
Journal:  Bone Marrow Transplant       Date:  2020-11-12       Impact factor: 5.483

Review 9.  The utility of phenomics in diagnosis of inherited metabolic disorders.

Authors:  Joyeeta Rahman; Shamima Rahman
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

Review 10.  Genetic Counseling and Genome Sequencing in Pediatric Rare Disease.

Authors:  Alison M Elliott
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.